Adrenaline Fresenius 1 mg/1 ml injection
PDF Leaflet Revision Date: 10 March 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of acute allergy and anaphylactic shock.
Dosage (summary)
Adults: 0.2 to 0.5 ml; Children: 0.1 to 0.3 ml.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use only if benefits justify risks; avoid breastfeeding.
Key Drug Interactions
- Monoamine oxidase inhibitors
- Non-cardioselective beta-blockers
- Halogenated anesthetics
Contraindications
- Hypersensitivity to sympathomimetics
- Ischaemic tissue necrosis risk in extremities
Common side effects
- Tachycardia
- Hypertension
- Anxiety
- Dizziness
Counselling Points
- Monitor continuously after administration.
- Avoid use in fingers/toes due to necrosis risk.
- Educate on signs of overdose.
Serious warnings
- Risk of severe hypertension and dysrhythmias
- Cerebral hemorrhage from IV use
Important Disclaimer
The Adrenaline Fresenius 1 mg/1 ml injection professional information leaflet below is the property of Fresenius Kabi Manufacturing Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
